DPZ
Domino's Pizza, Inc.
DPZ has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
DPZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Unavailable | |
| Weak |
DPZ's profitability is currently healthy, and its revenue is stable, but its balance sheet is weak. There isn't enough data to rate its cash flow.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DPZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $333 | — |
| Cheap | 24x | $438 | +31% |
| Fair | 29x | $521 | +56% |
| Expensive | 35x | $629 | +89% |
Historical ranges are pointers, not guarantees.
DPZ's PE is in its cheap range at 18x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
DPZ Forward outlook
There aren't enough analyst estimates for DPZ to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DPZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $18.15 | +6.1% |
| Q2 2026 | $17.63 | +2.4% |
| Q1 2026 | $17.37 | -0.4% |
| Q4 2025 | $17.57 | +5.3% |
| Q3 2025 | $17.11 | +5.2% |
| Q2 2025 | $17.22 | +5.9% |
| Q1 2025 | $17.44 | +14% |
| Q4 2024 | $16.69 | +14% |
DPZ has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
DPZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2B | +3.4% |
| Q2 2026 | $1.2B | +4.3% |
| Q1 2026 | $1.2B | +3.5% |
| Q4 2025 | $1.5B | +6.4% |
| Q3 2025 | $1.1B | +6.2% |
| Q2 2025 | $1.1B | +4.3% |
| Q1 2025 | $1.1B | +2.5% |
| Q4 2024 | $1.4B | +2.9% |
DPZ's revenue has grown year over year for 12 quarters in a row: $1.2B last quarter, up 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +0.9 points |
| Q2 2026 | 19% | -0.2 points |
| Q1 2026 | 20% | +1.1 points |
| Q4 2025 | 19% | +0.3 points |
| Q3 2025 | 19% | +1.1 points |
| Q2 2025 | 20% | +1.8 points |
| Q1 2025 | 19% | -0.5 points |
| Q4 2024 | 19% | +0.6 points |
DPZ has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over DPZ on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
DPZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $166.7M | -0.4% |
| Q1 2026 | $146.9M | -11% |
| Q2 2025 | $167.3M | +32% |
| Q1 2025 | $164.3M | +59% |
| Q2 2024 | $127.2M | +17% |
| Q1 2024 | $103.3M | +8% |
| Q2 2023 | $108.7M | +100% |
| Q1 2023 | $95.7M | +44% |
DPZ's free cash flow has been positive every quarter since early 2020: $645M over the past year, up 28% from the year before.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
DPZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.4x | High |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 4.6x | High |
| Q2 2025 | 4.7x | High |
| Q1 2025 | 4.8x | High |
| Q4 2024 | 5.0x | High |
| Q3 2024 | 5.0x | High |
DPZ's net debt is about 4.4 years of its operating earnings (EBITDA), down from 4.7 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DPZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.6 | Neutral |
| Stochastic | 52.0 | Neutral |
DPZ's weekly RSI is 52 (neutral) and its Stochastic is 52 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
DPZ PE vs Consumer Cyclical Sector
| Metric | DPZ | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 1.9% above |
| PE % | 4 | 47 | 43 pts below |
DPZ is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
DPZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $312.8 | 6.5% above |
| 20 week MA | $322.6 | 3.3% above |
| 50 week MA | $352.3 | 5.4% below |
| 100 week MA | $400.4 | 17% below |
| 200 week MA | $401.8 | 17% below |
DPZ has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
DPZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $292.3 | $396.7 | +36% |
| 2021 | $396.7 | $545.8 | +38% |
| 2022 | $545.8 | $353.0 | -35% |
| 2023 | $353.0 | $412.2 | +17% |
| 2024 | $412.2 | $429.6 | +4.2% |
| 2025 | $429.6 | $425.6 | -0.9% |
| 2026 YTD | $425.6 | $333.2 | -22% |
DPZ has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.